Company: MIRA
Filing Date: 2025-05-21
Form Type: 8-K
Source: 0001641172-25-011936
Chunk: 2

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-05-21
Form: 8-K
Item: Item 3.02
Chunk 2
---
 2025, between MIRA Pharmaceuticals, Inc. and Alan Weichselbaum.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                          

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                    MIRA                                          
  Dated:            By:                        /s/                
                    Name:                      Erez               
                    Title:                     Chief